Page 154 - CW E-Magazine (13-2-2024)
P. 154

News from Abroad



       CHEMICAL SAFETY ASSESSMENT
       BASF and partners join ECHA’s quest to find alternatives

       to animal testing


          The European Chemicals  Agency                                  researchers can then draw conclusions
       (ECHA) has contracted  a consortium                                about changes to cells or organs. Meta-
       that includes BASF to conduct scienti-                             bolomics technologies  can  be  used  to
       fic  studies  on  the  reliability  and  rele-                     study metabolic products in cells, such as
       vance  of New  Approach Methodo-                                   amino acids, lipids or hormones. If these
       logies (NAMs) as alternatives to animal                            change, the health of an organism can be
       testing and to promote the use of such                             evaluated, much like a diagnostic blood
       methods in the future.                                             test at the doctor’s office.

          The aim of the contract is to get ad-                              The research team aims to find out
       ditional NAMs accepted by regulatory                               under which  conditions  the  OMICS
       authorities, focusing on molecular bio-                            technologies can  reliably deliver rele-
       logical technologies (OMICS and toxico-  predictions. “This approach is already  vant  and  reproducible  findings  for  as-
       kinetics), and thereby further reduce  being used to close data gaps in regis-  sessing the safety of chemical substances.
       the number of animal studies conducted as  trations under the EU chemicals regula-  Regulatory authorities should  then be
       part of safety assessments for chemical  tion REACH. We would like to expand  able to consult these findings when as-
       substances. The contract will run for six  it further, for example, through the use  sessing the substances. This could also
       years and has a total value of €4.2-mn in  of molecular biological  methods. If  further reduce  the number of animal
       ECHA funding.                     grouping and read-across is correctly  studies needed in the future. The neces-
                                         applied,  there  is no longer a need to  sary regulatory guidelines also have to
          The contract research project is led  test every substance on  animals.  We  be developed.
       by the Fraunhofer Institute for  Toxi-  will therefore be able to further reduce
       cology and Experimental Medicine  the number of animal studies and the   The project will also evaluate
       (ITEM) in Hanover, Germany. ITEM,  costs for safety assessments,” said the  methods to predict the toxicokinetic
       Michabo Health Science, based in  toxicologist Professor Hennicke Kamp,  behaviour of substances in an organism,
       Coventry, England, and BASF Meta-  Managing Director at BASF  Meta-  including how they are absorbed,
       bolome Solutions in Berlin, Germany,  bolome Solutions.            distributed and excreted, as well as to
       are coordinating the work. Other part-                             evaluate the accumulation and degra-
       ners include the department for ex-  Role of OMICS technologies    dation of substances.  These methods
       perimental toxicology and ecology at   A major focus of the  research is  comprise  computational modelling
       BASF in Ludwigshafen, Germany, the  evaluating the  informative value  of  approaches, so-called  physiologically
       University of Birmingham in England  OMICS technologies in chemical safety   based kinetic (PBK) models. To facili-
       and the biotech companies BioClavis,  assessments. These technologies can be  tate the application and implementation
       based in Glasgow, Scotland, and   used to study, among other things, the  of such PBK  modelling data in regu-
       Novogene Europe, based in Cambridge,  activation  of genes (transcriptomics)  latory toxicology,  the  consortium will
       England.                          or entire metabolic processes (meta-  evaluate  the applicability  of PBK
                                         bolomics) in cultured cells or a living  models and their input parameters,  in
          The research partners will support  organism. With  OMICS  technologies,  particular the  in silico (in computers)
       ECHA in developing guidelines that  researchers can measure numerous dif-  and in vitro (experiments on cells, tissue
       can be used to reliably predict the pro-  ferent changes in a biological  sample  or organs and isolated under controlled
       perties of substances for which there  to extrapolate whether substances have   conditions outside the body) toxico-
       is not yet sufficient safety information.  a potentially hazardous effect. Transcripto-  kinetic parameters. A special focus is
       The grouping and read-across approach  mics can, for example,  determine   to better understand the performance
       uses existing safety data from structur-  how the activities  of genes change   and limitations  of these methods, the
       ally similar substances  to make these  after exposure to a certain substance. The   current knowledge and data gaps.


       154                                                                  Chemical Weekly  February 13, 2024


                                      Contents    Index to Advertisers    Index to Products Advertised
   149   150   151   152   153   154   155   156   157   158   159